FA
Forefront Analytics’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $257K | Buy |
+490
| New | +$257K | 0.29% | 32 |
|
|
2025
Q1 | – | Sell |
-368
| Closed | -$262K | – | 59 |
|
|
2024
Q4 | $262K | Buy |
368
+71
| +24% | +$50.6K | 0.12% | 49 |
|
|
2024
Q3 | $312K | Sell |
297
-31
| -9% | -$32.6K | 0.15% | 53 |
|
|
2024
Q2 | $345K | Sell |
328
-16
| -5% | -$16.8K | 0.17% | 52 |
|
|
2024
Q1 | $331K | Buy |
344
+25
| +8% | +$24.1K | 0.16% | 52 |
|
|
2023
Q4 | $280K | Buy |
319
+26
| +9% | +$22.8K | 0.14% | 53 |
|
|
2023
Q3 | $241K | Sell |
293
-48
| -14% | -$39.5K | 0.14% | 51 |
|
|
2023
Q2 | $245K | Sell |
341
-16
| -4% | -$11.5K | 0.14% | 51 |
|
|
2023
Q1 | $293K | Buy |
357
+50
| +16% | +$41.1K | 0.15% | 55 |
|
|
2022
Q4 | $221K | Sell |
307
-8
| -3% | -$5.77K | 0.12% | 60 |
|
|
2022
Q3 | $216K | Buy |
+315
| New | +$216K | 0.12% | 48 |
|
|
2022
Q2 | – | Sell |
-515
| Closed | -$353K | – | 71 |
|
|
2022
Q1 | $353K | Buy |
515
+123
| +31% | +$84.3K | 0.13% | 42 |
|
|
2021
Q4 | $249K | Buy |
392
+10
| +3% | +$6.35K | 0.08% | 50 |
|
|
2021
Q3 | $233K | Sell |
382
-40
| -9% | -$24.4K | 0.08% | 52 |
|
|
2021
Q2 | $235K | Sell |
422
-83
| -16% | -$46.2K | 0.09% | 53 |
|
|
2021
Q1 | $238K | Buy |
+505
| New | +$238K | 0.1% | 49 |
|